Impact of Dairy Consumption on Hypertension: a Clinical Study
PLAT
1 other identifier
interventional
80
1 country
1
Brief Summary
Hypertension and endothelial dysfunction are being increasingly recognized as key etiological factors in the development of atherosclerosis and subsequent cardiovascular disease (CVD). A substantial body of evidence indicates that treating patients with elevated blood pressure (BP) leads to marked reduction in the risk of stroke, myocardial infarction, heart failure, and renal failure. There is also accumulating evidence associating endothelial dysfunction, which is defined as incapacity of the arteries to vasodilate when required, to elevated BP and an increased risk of CVD. While there are more and more studies on how diet affects BP in healthy subjects, the impact of dairy consumption per se on both endothelial function and ambulatory BP has not been well characterized in patients with established essential hypertension. Therefore, the general objective of the study is to investigate in a single-blind randomized controlled study the impact of dairy consumption on ambulatory BP and endothelial function in subjects with mild to moderate essential hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Aug 2011
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 21, 2013
CompletedFirst Posted
Study publicly available on registry
January 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFebruary 7, 2014
February 1, 2014
1.6 years
January 21, 2013
February 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in mean daytime systolic blood pressure
Mean daytime systolic blood pressure will be measured by 24-h ambulatory blood pressure monitoring using the Spacelabs 90207 (Spacelabs, Inc., Redmond, WA)
At the fisrt visit of the study (screening) and at the end of the two 4-weeks diets (week 4 and week 12)
Secondary Outcomes (2)
Change in mean daytime diastolic blood pressure
At the first visit of the study (screening) and at the end of the two 4-weeks diets (week 4 and week 12)
Change in endothelial function
At the end of the two 4-weeks diets (week 4 and week 12)
Study Arms (2)
Dairy diet
EXPERIMENTALDuring the DAIRY diet, subjects will be asked to incorporate 3 servings of dairy into their everyday diet.
Control diet
PLACEBO COMPARATORDuring the CONTROL diet of the study, participants will be asked to consume energy equivalent replacement products into their everyday diet.
Interventions
During the DAIRY diet, subjects will be asked to incorporate 3 servings of dairy: 375 ml of reduced fat milk (1% fat), 175 g of low fat yogurt (1.5% fat) and 30g of regular cheese (34% fat) into their every day diet.
During the CONTROL diet of the study, participants will be asked to consume energy equivalent replacement products (290 ml of fruit juice, 156 ml of vegetable juice, 1 homemade cookie, 20g of cashew).
Eligibility Criteria
You may qualify if:
- Men and women aged between 18 and 70 years
- Mean daytime systolic blood pressure ≥ 135 mm Hg and ≤ 160 mm Hg
- Mean daytime diastolic blood pressure ≤ 110 mm Hg
- Consumption of dairy products fewer than 2 servings per day
You may not qualify if:
- Mean daytime systolic blood pressure \> 160 mm Hg
- Mean daytime diastolic blood pressure \> 110 mm Hg
- Dairy intake \> 2 serving per day
- Smokers (\>1 cigarette/day)
- Body weight variation \>10% during the last 6 months prior to the study baseline
- BMI \>35 kg/m2
- Previous history of cardiovascular disease, type 2 diabetes and monogenic dyslipidemia
- Subject taking anti-inflammatory drugs
- Subject with endocrine or gastrointestinal disorders
- Allergy, intolerance or aversion to dairy
- Clinical use of vitamin D or calcium supplements
- Vegetarians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
- Dairy Farmers of Canadacollaborator
Study Sites (1)
Institute of Nutraceuticals and Functional Foods (INAF)
Québec, Quebec, G1V 0A6, Canada
Related Publications (1)
Drouin-Chartier JP, Gigleux I, Tremblay AJ, Poirier L, Lamarche B, Couture P. Impact of dairy consumption on essential hypertension: a clinical study. Nutr J. 2014 Aug 14;13:83. doi: 10.1186/1475-2891-13-83.
PMID: 25123170DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Couture, MD,FRCP,PhD
Laval University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, FRCP, PhD
Study Record Dates
First Submitted
January 21, 2013
First Posted
January 28, 2013
Study Start
August 1, 2011
Primary Completion
March 1, 2013
Study Completion
December 1, 2013
Last Updated
February 7, 2014
Record last verified: 2014-02